Biotech's new financial layer.
Joined May 2022
- Tweets10.5K
- Following298
- Followers113K
- Likes25.2K
Bio Protocol retweeted
OpenLabs at the DeSci Summit, Mumbai
Recap of everything we showed of @openlabsbio at the DeSci Summit in Mumbai last week 👇
OpenLabs is one shared place to take an idea from curiosity to funded research. Interest in science is as high as it has ever been, while the path from an idea to a result still runs through months of admin that has little to do with the science.
→ A proposal takes around 116 hours to write before anyone reads it.
→ UK grant acceptance has declined to 19%, US health research to 13%, and EU early career grants to 8%.
→ 70% of high quality EU proposals go unfunded.
→ Reaching Nature averages 12,000 dollars, and a finished study can sit 17 months before anyone builds on it.
→ India produces 13% of the world's papers on under 1% of GDP spent on research.
The toolbox follows the order a project moves in.
BIOS refines a raw curiosity into a framed hypothesis while citing the OpenLabs index, and the index carries data models and research results including the failed and the ongoing.
→ Peer review happens in the open, with agents running editorial passes first so reviewers spend their time on higher order questions.
→ Challenges let a researcher ask the community for a skill or an answer, and the responses signal how much interest the work has.
→ Vaults take USDC deposits into DeFi yield and direct that yield to first grants.
→ The launchpad covers the pre-company stage, where a team has a goal and needs its angel round.
→ One unified MCP connects the index, OpenLabs, the launchpad and BioFy to the systems a team already runs.
The posts on OpenLabs today come from people outside institutions as much as inside them, including a fitness creator writing proposals on peptides in femtech.
Every breakthrough started as an untested idea that someone had room to pursue.
Bio Protocol retweeted
Spine surgeons came together to build FILTER, an AI tool for patient triage. Its new licensing deal creates a path into clinics, with the community keeping ownership and royalties supporting the next study.
Congrats to @Spine_DAO on taking this work forward!
Spine surgeons pooled their data and built an AI to get the right patient seen at the right time.
The community owns the IP and it’s now licensed to VECTOR SAS to bring it to clinics, with the royalty funding the next study.
That’s the DeSci loop, closed. FILTER live at @EFDevcon DeSci hub thanks to @DeSciIndia @DeSciAsia @messi_boii @swiftevo1
Bio Protocol retweeted
Our community funded the science. Now $VITARNA holders help decide the next experiment.
The bet underneath this vote: you don't have to repair every broken letter in your DNA. You just have to get the cell to read past it.
VRNAP-6 asks whether that changes how a mouse ages -> carried in every cell from birth, aged beside unedited littermates, judged on lifespan and healthspan.
@vitarnabio proposes testing it, starting with tolerability. No new raise.
👉Read the proposal and cast your vote.
snapshot.org/#/s:vitarna.eth…
As we age, cells pile up "stop" errors in their DNA that cut proteins short.
@artan_bio's Codon Therapy is built to read through them.
VRNAP-6 asks: do we test it for a whole lifetime?
🐭 Mice carry the fix from birth
📊 We track lifespan, frailty, grip, balance, gait 👇
Bio Protocol retweeted
What would happen if we could stop the functional consequences of somatic mutations we know accumulate over time?
Let's walk through what the data say. 🧬👇
@vitarnabio @vita_dao @artan_bio @Bodeeeman @aschwartzphd
Bio Protocol retweeted
Decentralized science is coming to Mumbai 🇮🇳
The Bio community is bringing researchers, founders and builders together for an afternoon of DeSci + AI with the first live demo of our lab robot, Robios.
Join us November 5 on the same grounds as @EFDevcon.
Sign up to attend and meet IRL ↓
Bio Protocol retweeted
How to write a useful claim on OpenLabs
A useful research claim gives others something specific to examine.
When sharing a hypothesis on OpenLabs, explain what you think is happening and what led you there. Then describe what evidence would support it, or make you reconsider.
Be clear about what you’ve observed and what you’re proposing.
Have a hypothesis you’re working on? Share it as a claim on OpenLabs. ↓
Bio Protocol retweeted
🧪 Lab update from @anagenxyz
They're preparing a Phase 1 PK study for MINX (vs standard 5 mg oral minoxidil), shipping the first topical diazoxide orders, and advancing several other programs(TWIST1, FOWLER imaging model, and more).
Full details ↓
Lab Roadmap, 10/21/2026:
MINX: Preparing an IRB submission for a Phase 1 single-dose crossover PK study. MINX vs regular oral minoxidil 5 mg in ~16 men.
DIAZOXIDE: First orders shipping now. Next week, we draw blood from 3 people to measure systemic absorption.
TWIST1: Lead sequences selected. Publication in progress on cell culture work. Penetration enhancers arrive next week. Mouse study to commence the following week.
OLANZAPINE, FARNESOL, NALTREXONE, DOXYCYCLINE: Imaging complete. RNA-seq analysis complete. Finalizing analysis of over 5000 images via tweaks to FOWLER. Publication to follow.
NEW PRODUCTS: Surprise. Surprise. An AR blocker, growth agonist, and novel peptide formulation all in development. More details to be revealed soon.
FOWLER: Our proprietary hair follicle labeling model severely outperforms Fable, Astra, and Muse. FOWLER is built on more than 6 TB of proprietary data.
RSPO: Imaging in progress. Over 2100 sections. To be completed in November.
TO BE ANNOUNCED: Next batch of gene therapies, small molecules, and formulations. Stay tuned.
Bio Protocol retweeted
Crypto is a dark forest. That is clear to all serious participants. We have priorities that address the issues that were observed in this launch:
- fix tokenomics
- incentivize capital formation, don't incentivize speculation
- smart contract logic > trust/promises (e.g. no fully liquid allocations to project/advisors)
- give projects an ecosystem to work and form an aligned community - before any token launch
- align scientific process with investor time-horizons
Onwards.
Update on NeuroLabs Ignition Sale
We want to clarify what happened during the launch and what we’re changing going forward.
1. Based on past launches, we intentionally didn’t communicate a specific finalization time to allow a buffer for the launch to finalize and for us to verify that everything was correct before distributing allocations. However, an outdated message from a previous deployment was still displayed on the finalization page, stating it would happen within 30 minutes. A disruption to our subgraph infrastructure delayed finalization leaving about an hour between the sale ending and TGE. We’re sorry for the wait.
2. We saw concerns about a wallet receiving tokens without participating in the Ignition Sale and selling shortly after. This wallet belonged to a NeuroLabs advisor and had been funded just before the launch. The advisor sold tokens representing 2.15% of the total supply.
NeuroLabs AI's tokenomics allocated 14.83% of the total supply to advisors, fully liquid at launch as communicated on the Bio launchpad sale page. We always recommend vesting for team, investor and advisor allocations but accepted the team's request to make the advisor allocation fully liquid for this launch. Going forward, we’ll enforce vesting for all team, investor and advisor allocations to better protect supporters.
3. From our side, we will refund all BioXP spent on the sale to all participants including those who purchased instant BioXP.
We believe DeSci should give projects the funding and community support to deliver on their roadmaps beyond the TGE.
We're building towards this through early community building and funding on OpenLabs, with permissionless launches and milestone-based funding in development for the Bio launchpad. The goal is to let projects focus on their scientific work, with supporters committed to that longer-term progress.
Thank you for your patience and continued trust as we build an ecosystem of tools and communities to move science forward.
Bio Protocol retweeted
The new PeptAI website is live 🧬
What's New:
• Pipeline overview: We’ve moved from a candidate view to a pipeline overview, making it easier to follow each project and see where everything stands.
• Start a project with us: Researchers and companies can now submit a research question or project idea through our contact form. Tell us what you’re working on and how we could help, and we’ll work with you to build a program around it.
Take a look ↓
Bio Protocol retweeted
NDT Ignition Sale Closed
@NootropicsDAO_ has exceeded its funding goal.
2.2x oversubscribed
442,646 USDC committed by 651 participants.
→ TGE is expected shortly.
→ NDT staking and rewards will go live shortly after the TGE.
→ veBIO holders receive NDT rewards, with 20% claimable at TGE and the remaining 80% vesting linearly over six months. Claiming before full vesting forfeits any remaining unvested tokens.
→ The snapshot for veBIO rewards has already been taken.
Bio Protocol retweeted
A few weeks ago I saw a post from @undiagnosed_1 and inspired by it, I reached out - he told me about his rare disease, and how it was misdiagnosed for years, including seven short read genomes from top providers.
His gene was sitting in a sequence gap, the 8% that short reads drop, and long read finally found it.
He then got a telomere to telomere genome from Karen Miga, the person behind the first complete human genome. 6.93 terabytes, and he was looking to find somebody to analyze it.
I told him to post about it on X.
@Codaracodes commented. A self taught biologist who learned genomics in a year.
They agreed on a project plan and they are now posting in public on @openlabsbio .
New features are coming that will support JJ's work. Results will be published with Research to the People.
DeSci at its best.
If you are sitting on data and nobody will fund the analysis, my DMs are open.
Bio Protocol retweeted
24 HOURS left in the $NDT Ignition Sale!
→ 165K+ USDC committed by 400+ participants
→ Sale ends Wednesday, Sep 30 at 4PM UTC
Participate in the sale with USDC & optionally BioXP.
No BioXP? Earn it through staking BIO or ecosystem tokens. Or mint it instantly by spending BIO.
app.bio.xyz/agents/neurolab-…
Bio Protocol retweeted
excellent paper from Deepmind on the specifics of agent fleets for science, and forward-thinking plans of the societal impact.
tokenizing science by @BioProtocol is mentioned as a great primitive cc: @paulkhls
Happy to share a new preprint: "Agentic Economies for Autonomous Scientific Discovery"
arxiv.org/abs/2609.31562
that encapsulates our thoughts on the AI revolution in science, and how applying an economic lens enables us to better recognize the key bottlenecks and how to address them.
Bio Protocol retweeted
New on OpenLabs: Dog Years DAO is exploring follistatin gene therapy for aging dogs 🐾
Joint pain can make dogs less active. Weight gain can then add more strain to their joints.
Tristan Roberts (@aitherick) and his team propose using plasmids, small pieces of DNA to help cells produce follistatin, a protein that regulates muscle growth.
Work in veterinary research or gene delivery? Explore the project and join the discussion ↓
Bio Protocol retweeted
AI co-scientists still need humans steering the work.
BIOS helps researchers move from a question to a candidate worth testing.
It searches literature, analyses data and designs candidate protein binders, then filters them into a computational shortlist.
Artificial-intelligence systems can generate hypotheses, design experiments and analyse data — but humans still need to decide what makes sense
go.nature.com/4rPJHYl
Bio Protocol retweeted
Finding the right open source scientific software shouldn't be the hard part of your research.
Open Science Index groups tools by scientific application. You start from your research problem and compare the options against each other.
We check the source registries daily, so you can see what is new and what is still maintained ↓
Bio Protocol retweeted
Launchpad wallets can now be funded by credit card.
Previously, funding a wallet meant buying elsewhere and transferring in. Card funding happens on the Launchpad itself, through @privy_io, and self-custody is unchanged: the wallet stays yours, and Bio never holds the funds.
This is the first step toward something larger. Most people who want to fund science don't hold crypto and shouldn't have to. We're building the rails that let fiat capital reach research directly, and removing each piece of friction between wanting to back a project and doing it.
Bio Protocol retweeted
New on OpenLabs: Synthetic TME for Cancer Therapeutics Discovery by @dominikus_brian
The project is exploring how to build models of the tumour microenvironment, the cells and conditions surrounding a tumour, for cancer research.
What is the smallest model that can help answer a specific question about a potential therapy?
The discussion focuses on:
• Which components are essential, from immune and stromal cells to oxygen levels?
• How should models be tested against patient samples and clinical data?
The work is at the research-planning stage, with model design and benchmarking questions open for input.
Explore the project and join the discussion ↓
Bio Protocol retweeted
Sometimes founders who i talk with think that raising money from our community is an easy ride, it is not.
Founders need to do three things to be successful with us.
1. Build in public. Posting daily on X and soon on openlabs, and the content must be high-quality, no AI slop.
2. Make sure the content is understandable by anyone without a scientific background.
3. Keep posting and pushing updates after the raise. The raise is just the beginning.
@anagenxyz in our ecosystem posts two to three times a day
If you are interested in building in public and getting funding from a community you build, my DMs are open